共 246 条
[1]
Kurtz SM(2012)Economic burden of periprosthetic joint infection in the United States J Arthroplast 27 61-65
[2]
Lau E(2016)The Economic Impact of Periprosthetic Infections After Total Hip Arthroplasty at a Specialized Tertiary-Care Center The Journal of Arthroplasty 31 1422-1426
[3]
Watson H(2016)Periprosthetic joint infection Lancet 387 386-394
[4]
Schmier JK(2013)Infectious diseases society of a: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America Clin Infect Dis 56 e1-e25
[5]
Parvizi J(2009)Complications after spacer implantation in the treatment of hip joint infections Int J Med Sci 6 265-458
[6]
Kapadia Bhaveen H.(2018)Viable bacteria persist on antibiotic spacers following two-stage revision for periprosthetic joint infection J Orthop Res 36 452-891
[7]
Banerjee Samik(2001)Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery J Antimicrob Chemother 47 885-149
[8]
Cherian Jeffrey J.(2003)Tobramycin and gentamycin elution analysis between two in situ polymerizable orthopedic composites J Biomed Mater Res B Appl Biomater 65 137-1566
[9]
Bozic Kevin J.(2018)Procedure for single-stage implant retention for chronic periprosthetic infection using topical degradable calcium-based antibiotics International Orthopaedics 43 1559-112228
[10]
Mont Michael A.(2017)Early results of adjuvant topical treatment of recurrent osteomyelitis with absorbable antibiotic carriers Z Orthop Unfall 12 0042-229